메뉴 건너뛰기




Volumn 189, Issue 2, 2000, Pages 62-

Managing patients with TSEs

(2)  Smith, A J a   Martin, M V a  

a NONE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CREUTZFELDT JAKOB DISEASE; DENTAL CARE; DISEASE TRANSMISSION; HUMAN; INFECTION CONTROL; NOTE; PRION DISEASE;

EID: 0034702458     PISSN: 00070610     EISSN: 17417503     Source Type: Journal    
DOI: 10.1038/sj.bdj.4800684     Document Type: Letter
Times cited : (2)

References (3)
  • 1
    • 0034701390 scopus 로고    scopus 로고
    • The human transmissable spongiform encephalopathies (TSEs): Implications for dental practitioners
    • Porter S, Scully C, Ridgway G L, Bell J. The human transmissable spongiform encephalopathies (TSEs): implications for dental practitioners. B Dent J 2000; 188: 432-436.
    • (2000) B Dent J , vol.188 , pp. 432-436
    • Porter, S.1    Scully, C.2    Ridgway, G.L.3    Bell, J.4
  • 2
    • 0033608367 scopus 로고    scopus 로고
    • Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: A case control study
    • Collins S, Law M G, Fletcher A, Boyd A, Kaldor J, Masters C L. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case control study. Lancet 1999; 353: 693-697.
    • (1999) Lancet , vol.353 , pp. 693-697
    • Collins, S.1    Law, M.G.2    Fletcher, A.3    Boyd, A.4    Kaldor, J.5    Masters, C.L.6
  • 3
    • 84984774762 scopus 로고    scopus 로고
    • Transmissible spongiform encephalopathy agents: Safe working and the prevention of infection
    • Advisory Committee on Dangerous Pathogens, Spongiform Encephalopathy Advisory Committee. Transmissible spongiform encephalopathy agents: safe working and the prevention of infection. HMSO 1998.
    • (1998) HMSO


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.